Delivery Order SPE2DB22D3004-SPE2DB24FPZ07
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NEXLETOL 180 MG TABLET UU 30S pharmaceutical products. The contract has a ceiling value of $3,714.60 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025,...
- This federal contract award is a $3,453.94 delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The delivery order is for the supply of NEXLETOL 180 MG TABLET, a specialty pharmaceutical product, with a completion date of February 8, 2024. Amerisourcebergen Drug Corp has an indefinite delivery contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,172.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nexletol 180 mg tablets (30-count units) with an ultimate completion date of September 24, 2025. This non-set-aside award was issued on September 23, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Nexletol 180 mg tablets (30-count units) on September 2, 2025, with a ceiling value of $2,667.56 and an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,383.52, is for the delivery of the pharmaceutical product NEXLETOL 180 MG TABLET UU 30S. The contract has an ultimate completion date of April 8, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,846.10 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 29, 2023. The award is for the supply of NEXLETOL 180 MG TABLET, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order with a ceiling value of $2,586.66 for the provision of NEXLETOL 180 MG TABLET to the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price agreement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,212.09 delivery order contract is for the provision of NEXLETOL 180 MG TABLET UU 30S. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a vehicle for supplying a comprehensive range of...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,736.73 award is for the supply of NEXLETOL 180 MG Tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,727.88 firm fixed-price delivery order is for the supply of NEXLETOL 180 MG TABLET, with an ultimate completion date of August 1, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPZ07Delivery Order
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DB22D3004|SPE2DB24FPZ07) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Nexletol 180 mg tablets. The $1,017.34 award has an ultimate completion date of April 15, 2024 and does not utilize a set-aside designation. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The parent company of AmerisourceBergen Drug Corp is Cencora, Inc., which does business as AmerisourceBergen.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/12/24 |